Luis Brieva Ruiz

Gil-Sanchez A; Canudes M; Valcheva P; Nogueras L; González-Mingot C; Hervás JV; Peralta S; Solana MJ; Brieva L

Effects of vortioxetine on cognition and fatigue in patients with multiple sclerosis and depression: a case series study.

CNS & Neurological Disorders-Drug Targets 23 395-401. 26/04/2023.

[doi:10.2174/1871527322666230321093133]

Lleixà C; Caballero-Ávila M; Pascual-Goñi E; Martín-Aguilar L; Vidal N; Tejada C; Valdés-Hevia E; Zárate E; Vesperinas A; Collet R; Franco-Leyva T; Martínez-Martínez L; Moga E; Cortés-Vicente E; Rojas-García R; Gómez-Anson B; Gil A; González-Mingot C; Brieva L; Martínez-Yélamos S; Querol L

Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.

Brain Communications 5 -. 04/04/2023.

[doi:10.1093/braincomms/fcad109]

Monreal, E; Fernandez-Velasco, JI; Garcia-Sanchez, MI; Sainz de la Maza S; Llufriu, S; Alvarez-Lafuente, R; Casanova, B; Comabella, M; Ramio-Torrenta, L; Martinez-Rodriguez, JE; Brieva, L; Saiz, A; Eichau, S; Cabrera-Maqueda, JM; Villarrubia, N; Espiño M; Perez-Miralles, F; Montalban, X; Tintore, M; Quiroga-Varela, A; Dominguez-Mozo, MI; Rodriguez-Jorge, F; Chico-Garcia, JL; Lourido, D; Alvarez-Cermeno, JC; Masjuan, J; Costa-Frossard, L; Villar, LM

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

JAMA Neurology 80 397-403. 01/04/2023.

[doi:10.1001/jamaneurol.2023.0010]

de la Maza, SS; Gómez-Ballesteros, R; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco-Quílez, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés-Redondo, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervàs, M; Medrano, N; Maurino, J; Castillo-Triviño, T

Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach

Multiple Sclerosis Journal-Experimental Translational And Clinical 9 -. 01/04/2023.

[doi:10.1177/20552173231169475]

Río J.; Peña J.; Brieva L.; García-Domínguez J.M.; Rodríguez-Antigüedad A.; Oreja-Guevara C.; Costa-Frossard L.; Arroyo R.

Monitoring response to disease-modifying treatment in multiple sclerosis

Neurology Perspectives 3 -. 01/01/2023.

[doi:10.1016/j.neurop.2023.100119]

de la Maza, SS; Maurino, J; Castillo-Triviño, T; Borges, M; Torres, BS; Sotoca, J; Torres, AMA; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco, MR; García-Soto, JD; Rodríguez-Regal, A; Navarro-Cantó, L; Agüera-Morales, E; Garcés, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; Gómez-Ballesteros, R

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

Patient Preference And Adherence 17 1431-1439. 01/01/2023.

[doi:10.2147/PPA.S411069]

Saposnik, Gustavo; Andhavarapu, Sanketh; Sainz de la Maza S; Castillo-Trivino, Tamara; Borges, Monica; Baron, Beatriz Pardinas; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco, Maria R.; -Soto, Julio Dotor Garcia; del Campo-Amigo, Maria; Navarro-Canto, Laura; Agüera E; Garces, Moises; Carmona, Olga; Gabaldon -Torres, Laura; Forero, Lucia; Hervas, Mariona; Garcia-Arcelay, Elena; Terzaghi, Maria; Gomez-Ballesteros, Rocio; Maurino, Jorge

Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.

Multiple Sclerosis and Related Disorders 68 104138-104138. 01/12/2022.

[doi:10.1016/j.msard.2022.104138]

González-Mingot, C; Gil-Sánchez, A; Canudes-Solans, M; Peralta-Moncusi, S; Solana-Moga, MJ; Brieva-Ruiz, L

Preventive treatment can reverse cognitive impairment in chronic migraine

JOURNAL OF HEADACHE AND PAIN 23 -. 01/12/2022.

[doi:10.1186/s10194-022-01486-w]

Meca-Lallana, J E; Fernandez-Prada, M; Garcia Vazquez, E; Moreno Guillen, S; Otero Romero, S; Rus Hidalgo, M; Villar Guimerans, L M; Eichau Madueño S; Fernandez Fernandez, O; Izquierdo Ayuso, G; Álvarez Cermeño JC; Arnal Garcia, C; Arroyo Gonzalez, R; Brieva Ruiz, L; Calles Hernandez, C; Garcia Merino, A; Gonzalez Plata, M; Hernandez Perez, M A; Moral Torres, E; Olascoaga Urtaza, J; Oliva-Nacarino, P; Oreja-Guevara, C; Ortiz Castillo, R; Oterino, A; Prieto Gonzalez, J M; Ramio-Torrenta, L; Rodriguez-Antiguedad, A; Saiz, A; Tintore, M; Montalban Gairin, X

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Neurologia (barcelona, Spain) 37 615-630. 01/10/2022.

[doi:10.1016/j.nrleng.2019.11.001]

Solari, A; Montalban, X; Lechner-Scott, J; Piehl, F; Brochet, B; Langdon, D; Hupperts, R; Selmaj, K; Havrdova, EK; Patti, F; Brieva, L; Maida, EM; Alexandri, N; Smyk, A; Nolting, A; Keller, B

Improvements in quality of life over 2 years in patients treated with cladribine tablets for highly active relapsing multiple sclerosis: Final analysis of CLARIFY-MS

MULTIPLE SCLEROSIS JOURNAL 28 203-204. 01/10/2022.

Martín-Aguilar L.; Presas-Rodriguez S.; Rovira À.; Capellades J.; Massuet-Vilamajó A.; Ramió-Torrentà L.; Tintoré M.; Brieva-Ruiz L.; Moral E.; Cano-Orgaz A.; Blanco Y.; Batlle-Nadal J.; Carmona O.; Gea M.; Hervás-García J.V.; Ramo-Tello C.

Gadolinium-enhanced brain lesions in multiple sclerosis relapse

NEUROLOGIA 37 557-563. 01/09/2022.

[doi:10.1016/j.nrl.2021.10.005]

Castillo-Trivino, Tamara; Gomez-Ballesteros, Rocio; Borges, Monica; Martin-Martinez, Jesus; Sotoca, Javier; Alonso, Ana; Caminero, Ana B.; Borrega, Laura; Sanchez-Menoyo, Jose L.; Barrero-Hernandez, Francisco J.; Calles, Carmen; Brieva, Luis; Blasco-Quilez, Maria R.; Garcia-Soto, Julio Dotor; del Campo-Amigo, Maria; Navarro-Canto, Laura; Aguera, Eduardo; Garces-Redondo, Moises; Carmona, Olga; Gabaldon-Torres, Laura; Forero, Lucia; Hervas, Mariona; Mauriño J; Sainz de la Maza S

Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.

Multiple Sclerosis and Related Disorders 64 103969-103969. 01/08/2022.

[doi:10.1016/j.msard.2022.103969]